Prostate Cancer Expectant Management On the Rise
Patients diagnosed with the cancer in 2011 were 2.5 times more likely to be managed expectantly than those diagnosed in 2004.
Print Issue: March 01, 2014
Kidney Cancer Survival Improved by BP Drugs
ACE inhibitors and angiotensin receptor blockers were shown to prolong median overall survival by nine months.
Lethal Prostate Cancer Less Likely in Men with AB Blood
The risk of PCa death or distant metastases is 61% lower in men with blood group AB compared with those who have blood group O.
Enzalutamide, Combination RT Benefits Metastatic PCa
And, combination radiotherapy, anti-androgen tx improves survival in locally advanced disease.
Reduced Kidney Function Linked to Rheumatoid Arthritis
The presence of cardiovascular disease in RA patients increases their risk of impaired renal function.
Bladder Cancer Linked to HER2 Breast Cancer Gene
Study demonstrates an association with micropapillary urothelial carcinoma.
Gene Mutations May Enable Targeted PSA Screening
The BRCA2 gene mutation is associated with a significantly increased likelihood of intermediate- or high-risk prostate cancer.
Sickle Cell Trait May Raise Need for Anemia Meds in Dialysis Patients
This trait in African-American hemodialysis patients was associated with a 13.2% higher dose of erythropoiesis-stimulating agents.
Drug Shows Promise for Post-Transplant New-Onset Diabetes
Sitagliptin was well tolerated and it significantly increased insulin secretion and reduced glucose levels.
Low Testosterone May Predict Worse Prostate Cancer Outcomes
Preoperative levels below 300 ng/dL are associated with an increased risk of positive surgical margins and seminal vesicle invasion.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...